Fenofibrate: all 132 studies that test it
Page 2 of 2. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting ConditionsCompletedNCT00775827Not applicable
- Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed ConditionsCompletedNCT00775359Not applicable
- Study to Compare Welchol and TriCor to TriCor Alone in Patients With High CholesterolCompletedNCT00754039Phase 4
- Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic PatientsCompletedNCT00745407Phase 4
- Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With FenofibrateWithdrawnNCT00732485Phase 2/3
- A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.CompletedNCT00703755Phase 2
- A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 DiabetesCompletedNCT00703482Phase 2
- Pharmacological Regulation of Fat Transport in Metabolic SyndromeCompletedNCT00632840Phase 4
- Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical FunctionStatus unknownNCT00627653Not applicable
- Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart DiseaseCompletedNCT00552747Phase 4
- Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy PeopleCompletedNCT00543647Phase 1
- Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and DyslipidemiaCompletedNCT00490178Phase 3
- Tissue Lipids and Insulin ResistanceWithdrawnNCT00483210Not applicable
- High-Density Lipoprotein (HDL) Treatment StudyCompletedNCT00458055Not applicable
- Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and ThrombosisCompletedNCT00422396Not applicable
- The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) StudyCompletedNCT00400231Phase 2
- Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033WithdrawnNCT00376285Phase 1
- Comparison of the Combination of Fenofibrate and Simvastatin Versus AtorvastatinCompletedNCT00362934Phase 3
- Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics StudyTerminatedNCT00362765Phase 2/3
- Comparison of the Combination of Fenofibrate and Simvastatin Versus PravastatinCompletedNCT00362206Phase 3
- Substrate Cycling in Energy MetabolismCompletedNCT00361751Phase 2
- Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin MonotherapyCompletedNCT00352183Phase 3
- A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.CompletedNCT00349635Phase 2
- Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin MonotherapyCompletedNCT00349375Phase 3
- Diabetes and Combined Lipid Therapy Regimen (DIACOR) StudyCompletedNCT00309712Not applicable
- GALLANT 14 Tesaglitazar vs. Metformin and FenofibrateTerminatedNCT00261352Phase 3
- Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week ExtensionCompletedNCT00246636Phase 4
- A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to AtorvastatinCompletedNCT00195793Phase 3
- Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.TerminatedNCT00145431Phase 3
- Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. FenofibrateCompletedNCT00139061Phase 3
- The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)CompletedNCT00076518Phase 2
- Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood LipidsCompletedNCT00006412Phase 3